4/A

FORM 4/A SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: September 17, 2020
Period of Report: September 13, 2020
Accession Number: 0001209191-20-050986

View Document ↗ View on SEC.gov ↗